Definitive Contract W911QY21C0012

Award Date 11/9/20
Potential Completion Date 12/15/22
Potential Value $14M
Contracting Federal Agency
ACC Aberdeen Proving Ground
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
St Cloud, MN 56303, USA
Solicitation Procedures
Two Step
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $9.8 million firm fixed price delivery order contract to Cepheid, a subsidiary of Danaher Corporation, for COVID-19 assay kits. The contract supports the Department of Defense's response to the Coronavirus Disease 2019 national emergency through the procurement of testing materials under the Coronavirus COVID-19 national interest program. Performance will take place in Aberdeen, Maryland...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $5.9 million firm fixed price delivery order to Biofire Defense LLC. The order is for the purchase of COVID-19 assays, external control materials, and software module updates to support the agency's response to the Coronavirus pandemic. Performance will take place in Salt Lake City, Utah, through December 2020. No set aside designation or subcontractors were indicated. The funding agency...
The Department of the Army Medical Command awarded a $518,400 purchase order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division for reagents and assays in support of the Coronavirus COVID-19 national interest. The contract was awarded under the agency's $20 million Coronavirus program and will provide the requested products for use at the prime contractor's location in Marlborough, Massachusetts between April 6th and 17th, 2020. A firm fixed price was established for this...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $12.8 million firm fixed price purchase order to Cepheid, a subsidiary of Danaher Corporation, for XPRSARS-COV2-10 TESTS. The contract is being funded by the Army to support the national interest in response to the Coronavirus COVID-19 and will provide Cepheid's coronavirus tests. Performance will occur in Sunnyvale, California over a 10 month period concluding in March 2021. No...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $2.9 million firm fixed price delivery order to Cepheid, a subsidiary of Danaher Corporation, to provide 16 Genexpert XPCOV2/FLU/RSV-10 systems with one year of service. The systems will support COVID-19 testing and be located in Aberdeen, Maryland. Funding comes from the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to support coronavirus...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $1,312,325 firm fixed price delivery order contract to Cepheid, a subsidiary of Danaher Corporation, to provide XPCOV2/FLU/RSV-10 tests. The contract will be performed in Aberdeen, Maryland from January 11, 2022 through March 4, 2022 in support of the Coronavirus COVID-19 national interest. Cepheid will supply its tests for the SARS-CoV-2, influenza, and respiratory syncytial virus pathogens...
The U.S. Defense Logistics Agency Troop Support Medical awarded a $10,880 fixed-price delivery order to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases. The contract is for the provision of SARS-CoV-2/Flu/RSV+ testing products and is set to run through January 8, 2024. Cepheid, as the prime contractor, will deliver reagents, test kits, instruments, and testing platforms to support the clinical diagnostic programs of the agency. This...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency Troop Support Medical to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $9,520.00 and an ultimate completion date of July 5, 2024. The contract is for the provision of XPCOV2/FLU/RSV-10 diagnostic tests, which are used to detect COVID-19, influenza, and respiratory syncytial virus. Cepheid has a history of federal contract awards, including indefinite...
This is a federal contract award to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $1,090,122.90, is a Delivery Order issued by the Defense Health Agency (DHA) for SARS-COV-2/FLU PCR testing products and services. The contract has an ultimate completion date of September 30, 2025. Cepheid, the prime contractor, is an original equipment manufacturer and a provider of comprehensive molecular diagnostic technologies to various federal agencies,...
The Department of Defense's Joint PEO Chemical and Biological Defense awarded a $26,642.70 firm-fixed-price delivery order to Meso Scale Diagnostics LLC, a for-profit limited liability company, for monthly status reports (CDRL A001). This order is part of a larger indefinite delivery contract to provide the Army with multiplex assay kits, components, and related services supporting chemical/biological defense efforts. Meso Scale Diagnostics, a provider of assay development, testing equipment,...

This definitive contract from the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense (JPEO-CBRND) awards Microbiologics, Inc. $13.6 million to deliver technology transfer of reporter VN assay in support of advanced SARS-CoV-2 medical countermeasure therapeutics. The solicitation sought proposals to manufacture and fill-finish a minimum of 100,000 treatment courses by March 2021 to treat the indicated U.S. population, with candidate therapeutics demonstrating capability for Emergency Use Authorization or FDA approval by end of 2020. The firm fixed-price contract runs from November 2020 through December 2022 for performance in St. Cloud, Minnesota and supports JPEO-CBRND and Biomedical Advanced Research and Development Authority's Commercial Solutions Opening solicitation to strengthen the U.S. medical response against COVID-19. There is no set-aside designation for this award to Microbiologics, Inc. for reporter VN assay technology transfer.

Generated 12/29/23, 4:03 PM